2026 SPS Twin Cities | Datopotamab Deruxtecan Therapy Considerations in the Management of Unresectable or Metastatic Hormone Receptor-Positive
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- Sep 22, 2026
- Last Review
- Sep 23, 2026
- Expires
- Sep 23, 2029
Target Audience
Pharmacists
Nurses
Accreditation
N/A
Related Courses
2026 SPS Twin Cities | Hyaluronidase Delivering New Subcutaneous Dosage Forms Throughout Various Therapeutic Areas: A Dive into Clinical, Safety, Practice and Economic Considerations
0.00 Credits
1 Chapter
Pharmacology
Free
2026 SPS Twin Cities | CMS Drug Price Negotiations Through Maximum Fair Price (MFP): Access & Practice Considerations Now & Then
0.00 Credits
1 Chapter
Pharmacology
Free